JP2006524672A5 - - Google Patents

Download PDF

Info

Publication number
JP2006524672A5
JP2006524672A5 JP2006506149A JP2006506149A JP2006524672A5 JP 2006524672 A5 JP2006524672 A5 JP 2006524672A5 JP 2006506149 A JP2006506149 A JP 2006506149A JP 2006506149 A JP2006506149 A JP 2006506149A JP 2006524672 A5 JP2006524672 A5 JP 2006524672A5
Authority
JP
Japan
Prior art keywords
furo
decyl
pyrimidin
pyrimidine
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006506149A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006524672A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2004/001687 external-priority patent/WO2004096813A1/en
Publication of JP2006524672A publication Critical patent/JP2006524672A/ja
Publication of JP2006524672A5 publication Critical patent/JP2006524672A5/ja
Withdrawn legal-status Critical Current

Links

JP2006506149A 2003-04-25 2004-04-21 ウイルス感染の治療において使用するための複素環式化合物 Withdrawn JP2006524672A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0309506 2003-04-25
PCT/GB2004/001687 WO2004096813A1 (en) 2003-04-25 2004-04-21 Heterocyclic compounds for use in the treatment of viral infections

Publications (2)

Publication Number Publication Date
JP2006524672A JP2006524672A (ja) 2006-11-02
JP2006524672A5 true JP2006524672A5 (https=) 2009-04-16

Family

ID=33397005

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006506149A Withdrawn JP2006524672A (ja) 2003-04-25 2004-04-21 ウイルス感染の治療において使用するための複素環式化合物

Country Status (7)

Country Link
US (1) US20070191373A1 (https=)
EP (1) EP1622913A1 (https=)
JP (1) JP2006524672A (https=)
AU (1) AU2004234110A1 (https=)
CA (1) CA2523739A1 (https=)
MX (1) MXPA05010802A (https=)
WO (1) WO2004096813A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083923A (en) * 1997-10-31 2000-07-04 Isis Pharmaceuticals Inc. Liposomal oligonucleotide compositions for modulating RAS gene expression
EP2318415B1 (en) 2008-07-15 2013-02-20 Sanofi Oxazolopyrimidines as edg-1 receptor agonists
AR079980A1 (es) 2010-01-13 2012-03-07 Sanofi Aventis Derivados de oxazolopirimidina sustituida en 2,5,7
AR079981A1 (es) 2010-01-13 2012-03-07 Sanofi Aventis Derivados de acido carboxilico que comprenden un anillo de oxoazolopirimidina 2,5,7- sustituido
CN102834400B (zh) * 2010-01-14 2015-06-10 赛诺菲 2,5-取代的*唑并嘧啶衍生物
CN102791717B (zh) * 2010-01-14 2016-03-30 赛诺菲 具有2,5-取代的噁唑并嘧啶环的羧酸衍生物
AR082453A1 (es) 2010-04-21 2012-12-12 Novartis Ag Compuestos de furopiridina, composiciones farmaceuticas que los contienen y usos de los mismos
GB201111779D0 (en) 2011-07-08 2011-08-24 Univ Cardiff Chemical compounds
WO2014140077A1 (en) 2013-03-14 2014-09-18 Glaxosmithkline Intellectual Property (No.2) Limited Furopyridines as bromodomain inhibitors
BR112022025710A2 (pt) 2020-06-19 2023-03-07 Bayer Ag 1,3,4-oxadiazol pirimidinas e 1,3,4-oxadiazol piridinas como fungicidas

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2444148A1 (en) * 2001-04-11 2002-10-24 Queen's University At Kingston Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents

Similar Documents

Publication Publication Date Title
JP2006524672A5 (https=)
AU781323B2 (en) Anti-viral pyrimidine nucleoside analogues
JP2008538771A5 (https=)
JP2001525411A5 (https=)
Reddy et al. 2′-Deoxy-2′-α-fluoro-2′-β-C-methyl 3′, 5′-cyclic phosphate nucleotide prodrug analogs as inhibitors of HCV NS5B polymerase: Discovery of PSI-352938
EP2223927A3 (en) Cyclic phosphonic acid based prodrugs of PMEA and its analogues
JP2003532735A5 (https=)
CY1109785T1 (el) Παραγωγα πυριδοϊνδολονης που φερει υποκαταστατη στο -3 απο ενα φαινυλιο, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη
EP1383778A4 (en) AGONISTS AND ANTAGONISTS OF SPHINGOSIN-1 PHOSPHATE RECEPTORS
Piperno et al. Synthesis and Biological Activity of Phosphonated Nucleosides: Part 1Furanose, Carbocyclic and Heterocyclic Analogues
NZ553405A (en) Nucleoside phosphonate conjugates as anti-HIV agents
KR930006036A (ko) 퓨린 및 피리미딘의 불포화 비환식 포스포네이트 유도체
JP2009536650A5 (https=)
HRP20120820T1 (hr) Spoj uracila koji ima inhibicijsko djelovanje na humanu deoksiuridin trifosfatazu ili njegove soli
JP2004002414A5 (https=)
EP2196454A3 (en) Exo-and diastereo-selective syntheses of himbacine analogs
EP2922859A1 (en) Phosphonucleosides useful in the treatment of viral disorders
CA2530374A1 (en) Hsp90 family protein inhibitors
DK1294705T3 (da) Syntese af cykliske forbindelser
JP2006503143A5 (https=)
US20040014722A1 (en) Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
JP2015521192A5 (https=)
WO2012024625A3 (en) Novel synthesis of nucleoside 5 ' -triphosphates and their derivatives
WO2016174081A1 (en) Novel antiviral compounds, a process for their preparation, and their use for treating viral infections
PL378343A1 (pl) Pochodne benzoksazolu i ich zastosowanie jako ligandów receptora adenozyny